Quick Answer
Eton Pharmaceuticals, Inc. reported Net Income of -$4.60 million for fiscal year 2025.
Eton Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$4.60M | -20.4% |
| 2024 | -$3.82M | -308.4% |
| 2023 | -$936.0K | +89.6% |
| 2022 | -$9.02M | -361.4% |
| 2021 | -$1.96M | +93.0% |
| 2020 | -$27.97M | -52.7% |
| 2019 | -$18.32M | -43.8% |
| 2018 | -$12.74M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.93M | -407.3% | +25.5% |
| June 30, 2025 | -$2.58M | +15.0% | -64.4% |
| March 31, 2025 | -$1.57M | -93.8% | -350.7% |
| September 30, 2024 | $627.0K | +208.3% | +120.6% |
| June 30, 2024 | -$3.04M | -166.7% | -275.0% |
| March 31, 2024 | -$811.0K | +69.5% | -40.1% |
| September 30, 2023 | -$579.0K | +81.0% | -112.7% |
| June 30, 2023 | $4.56M | +392.6% | +271.4% |
- Eton Pharmaceuticals, Inc. showed a decrease of -20.4% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Eton Pharmaceuticals, Inc.’s net income has grown by 63.9% (from -$12.74 million to -$4.60 million).
- The most recent figure is from Eton Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: